Evaluation of Screening Program and Phylogenetic Analysis of SARS-CoV-2 Infections among Hospital Healthcare Workers in Liège, Belgium.

COVID-19 SARS-CoV-2 healthcare workers healthcare-associated transmission infection prevention and control occupational exposure phylogenetic analysis

Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
14 06 2022
Historique:
received: 16 04 2022
revised: 03 06 2022
accepted: 09 06 2022
entrez: 24 6 2022
pubmed: 25 6 2022
medline: 28 6 2022
Statut: epublish

Résumé

Healthcare workers (HCWs) are known to be at higher risk of developing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections although whether these risks are equal across all occupational roles is uncertain. Identifying these risk factors and understand SARS-CoV-2 transmission pathways in healthcare settings are of high importance to achieve optimal protection measures. We aimed to investigate the implementation of a voluntary screening program for SARS-CoV-2 infections among hospital HCWs and to elucidate potential transmission pathways though phylogenetic analysis before the vaccination era. HCWs of the University Hospital of Liège, Belgium, were invited to participate in voluntary reverse transcriptase-polymerase chain reaction (RT-PCR) assays performed every week from April to December 2020. Phylogenetic analysis of SARS-CoV-2 genomes were performed for a subgroup of 45 HCWs. 5095 samples were collected from 703 HCWs. 212 test results were positive, 15 were indeterminate, and 4868 returned negative. 156 HCWs (22.2%) tested positive at least once during the study period. All SARS-CoV-2 test results returned negative for 547 HCWs (77.8%). Nurses (p < 0.05), paramedics (p < 0.05), and laboratory staff handling respiratory samples (p < 0.01) were at higher risk for being infected compared to the control non-patient facing group. Our phylogenetic analysis revealed that most positive samples corresponded to independent introduction events into the hospital. Our findings add to the growing evidence of differential risks of being infected among HCWs and support the need to implement appropriate protection measures based on each individual’s risk profile to guarantee the protection of both HCWs and patients. Furthermore, our phylogenetic investigations highlight that most positive samples correspond to distinct introduction events into the hospital.

Identifiants

pubmed: 35746774
pii: v14061302
doi: 10.3390/v14061302
pmc: PMC9227503
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Elife. 2020 May 11;9:
pubmed: 32392129
Clin Microbiol Infect. 2020 Oct;26(10):1413.e9-1413.e13
pubmed: 32569835
N Engl J Med. 2020 May 21;382(21):2005-2011
pubmed: 32220208
Sci Rep. 2022 Mar 25;12(1):5156
pubmed: 35338237
Euro Surveill. 2020 Apr;25(14):
pubmed: 32290904
JAMA Netw Open. 2020 May 1;3(5):e209666
pubmed: 32437575
Philos Trans R Soc Lond B Biol Sci. 2021 Jul 19;376(1829):20200268
pubmed: 34053255
JAMA. 2020 Jul 14;324(2):195-197
pubmed: 32539107
Infect Dis (Lond). 2021 Jun;53(6):460-468
pubmed: 33689558
Pathogens. 2021 Oct 21;10(11):
pubmed: 34832518
N Engl J Med. 2020 Mar 26;382(13):1194-1196
pubmed: 32074416
Elife. 2020 Jun 19;9:
pubmed: 32558644
Ann Intern Med. 2021 May;174(5):649-654
pubmed: 33513035
Mol Biol Evol. 2021 Apr 13;38(4):1608-1613
pubmed: 33316043
Virus Evol. 2018 Jun 08;4(1):vey016
pubmed: 29942656
Lancet Infect Dis. 2020 Dec;20(12):1401-1408
pubmed: 32758438
Antimicrob Resist Infect Control. 2021 Jan 6;10(1):7
pubmed: 33407833
Elife. 2020 Aug 21;9:
pubmed: 32820721
Syst Biol. 2018 Sep 1;67(5):901-904
pubmed: 29718447
Infect Prev Pract. 2022 Mar;4(1):100192
pubmed: 34870142
Clin Infect Dis. 2020 Nov 19;71(16):2218-2221
pubmed: 32179890
Virus Evol. 2018 Jan 08;4(1):vex042
pubmed: 29340210
Nat Commun. 2020 Oct 8;11(1):5064
pubmed: 33033249
Biol Methods Protoc. 2020 Jul 18;5(1):bpaa014
pubmed: 33029559
N Engl J Med. 2020 Dec 17;383(25):2417-2426
pubmed: 33176077
Clin Infect Dis. 2022 Mar 9;74(5):829-835
pubmed: 34328176
Clin Microbiol Infect. 2021 Sep;27(9):1336-1344
pubmed: 34020033
Am J Epidemiol. 2021 Jan 4;190(1):161-175
pubmed: 32870978
BMC Psychol. 2021 Dec 17;9(1):195
pubmed: 34920763
mSphere. 2021 Aug 25;6(4):e0038921
pubmed: 34346709
Arch Public Health. 2021 Oct 27;79(1):188
pubmed: 34706768
PLoS One. 2021 Mar 18;16(3):e0248347
pubmed: 33735264
Infect Control Hosp Epidemiol. 2022 Mar;43(3):326-333
pubmed: 33736734
PLoS Med. 2021 Oct 12;18(10):e1003816
pubmed: 34637439
Int J Environ Res Public Health. 2021 Apr 25;18(9):
pubmed: 33922895
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Sci Rep. 2021 Sep 17;11(1):18580
pubmed: 34535691
Clin Infect Dis. 2021 Sep 15;73(6):e1329-e1336
pubmed: 33857303
J Infect Dis. 2022 Jan 5;225(1):10-18
pubmed: 34555152
Elife. 2021 Mar 17;10:
pubmed: 33729154
Viruses. 2021 Apr 01;13(4):
pubmed: 33916205
Healthcare (Basel). 2021 Nov 02;9(11):
pubmed: 34828540
Front Med (Lausanne). 2021 Mar 12;8:636160
pubmed: 33777979
Mol Biol Evol. 2020 May 1;37(5):1530-1534
pubmed: 32011700
Genetics. 1995 Feb;139(2):993-1005
pubmed: 7713447
Lancet Infect Dis. 2020 Nov;20(11):1273-1280
pubmed: 32622380
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
Antimicrob Resist Infect Control. 2022 Mar 18;11(1):51
pubmed: 35303939
Clin Infect Dis. 2021 Jun 1;72(11):e727-e735
pubmed: 32954414
Can J Psychiatry. 2007 Apr;52(4):241-7
pubmed: 17500305
Lancet. 2020 May 2;395(10234):e77-e78
pubmed: 32333843
Open Forum Infect Dis. 2020 Dec 09;8(1):ofaa582
pubmed: 33447642
JAMA Netw Open. 2021 Mar 1;4(3):e211283
pubmed: 33688967
Sci Rep. 2022 Jan 20;12(1):1094
pubmed: 35058525
Lancet Infect Dis. 2020 Nov;20(11):1263-1272
pubmed: 32679081
J Hosp Infect. 2021 Apr;110:178-183
pubmed: 33571558
Lancet Public Health. 2020 Sep;5(9):e475-e483
pubmed: 32745512
Curr Infect Dis Rep. 2003 Dec;5(6):473-476
pubmed: 14642187
JAMA Netw Open. 2021 Jul 1;4(7):e2118554
pubmed: 34319354
PLoS Comput Biol. 2009 Sep;5(9):e1000520
pubmed: 19779555

Auteurs

Majdouline El Moussaoui (M)

Department of Infectious Diseases and General Internal Medicine, University Hospital of Liège, 4000 Liege, Belgium.

Nathalie Maes (N)

Department of Biostatistics and Medico-Economic Information, University Hospital of Liège, 4000 Liege, Belgium.

Samuel L Hong (SL)

Department of Microbiology, Immunology and Transplantation, Rega Institute, Katholieke Universiteit Leuven, 3000 Leuven, Belgium.

Nicolas Lambert (N)

Department of Neurology, University Hospital of Liège, 4000 Liege, Belgium.

Stéphanie Gofflot (S)

Department of Biothèque Hospitalo-Universitaire de Liège (BHUL), University Hospital of Liège, 4000 Liege, Belgium.

Patricia Dellot (P)

Department of Infectious Diseases and General Internal Medicine, University Hospital of Liège, 4000 Liege, Belgium.

Yasmine Belhadj (Y)

Department of Infectious Diseases and General Internal Medicine, University Hospital of Liège, 4000 Liege, Belgium.

Pascale Huynen (P)

Department of Clinical Microbiology, University Hospital of Liège, 4000 Liege, Belgium.

Marie-Pierre Hayette (MP)

Department of Clinical Microbiology, University Hospital of Liège, 4000 Liege, Belgium.

Cécile Meex (C)

Department of Clinical Microbiology, University Hospital of Liège, 4000 Liege, Belgium.

Sébastien Bontems (S)

Department of Clinical Microbiology, University Hospital of Liège, 4000 Liege, Belgium.

Justine Defêche (J)

Department of Clinical Microbiology, University Hospital of Liège, 4000 Liege, Belgium.

Lode Godderis (L)

Centre for Environment and Health, Department of Public Health and Primary Care, Katholieke Universiteit Leuven, 3000 Leuven, Belgium.

Geert Molenberghs (G)

Institute for Biostatistics and Statistical Bioinformatics, Katholieke Universiteit Leuven, 3000 Leuven, Belgium.

Christelle Meuris (C)

Department of Infectious Diseases and General Internal Medicine, University Hospital of Liège, 4000 Liege, Belgium.

Maria Artesi (M)

Laboratory of Human Genetics, GIGA-Institute, University of Liège, 4000 Liege, Belgium.

Keith Durkin (K)

Laboratory of Human Genetics, GIGA-Institute, University of Liège, 4000 Liege, Belgium.

Souad Rahmouni (S)

Laboratory of Animal Genomics, GIGA-Medical Genomics, GIGA-Institute, University of Liège, 4000 Liege, Belgium.

Céline Grégoire (C)

Department of Haematology, University Hospital of Liège, 4000 Liege, Belgium.

Yves Beguin (Y)

Department of Haematology, University Hospital of Liège, 4000 Liege, Belgium.

Michel Moutschen (M)

Department of Infectious Diseases and General Internal Medicine, University Hospital of Liège, 4000 Liege, Belgium.

Simon Dellicour (S)

Department of Microbiology, Immunology and Transplantation, Rega Institute, Katholieke Universiteit Leuven, 3000 Leuven, Belgium.
Spatial Epidemiology Lab, Université Libre de Bruxelles, 1000 Brussels, Belgium.

Gilles Darcis (G)

Department of Infectious Diseases and General Internal Medicine, University Hospital of Liège, 4000 Liege, Belgium.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH